FDA panel backs Sage's novel antidepressant but turns down ... - pharmaphorum

pharmaphorumFDA panel backs Sage's novel antidepressant but turns down ...pharmaphorumSage's Zulresso is on course for approval for postnatal depression in the US after a positive vote from an FDA advisory committee.FDA Panel Backs Novel Treatment for Postpartum DepressionMedscapeFDA panel backs Sage's postpartum depression drug in 17-1 voteFierceBiotechSage's postpartum depression treatment benefits outweigh risk: FDA ...Business Insiderall 13 news articles »